{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:54:29Z","timestamp":1789206869087,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T00:00:00Z","timestamp":1450915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T00:00:00Z","timestamp":1450915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/gt.2015.114","type":"journal-article","created":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T15:40:38Z","timestamp":1450971638000},"page":"296-305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Efficacy and safety of myocardial gene transfer of adenovirus, adeno-associated virus and lentivirus vectors in the mouse heart"],"prefix":"10.1038","volume":"23","author":[{"given":"M","family":"Merentie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Lottonen-Raikaslehto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Parviainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Huusko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Pikkarainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Laham-Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"K\u00e4rj\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Rissanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Yl\u00e4-Herttuala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,24]]},"reference":[{"key":"BFgt2015114_CR1","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095\u20132128.","journal-title":"Lancet"},{"key":"BFgt2015114_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1242\/dmm.010413","volume":"6","author":"G Dragneva","year":"2013","unstructured":"Dragneva G, Korpisalo P, Yla-Herttuala S . Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success. Dis Model Mech 2013; 6: 312\u2013322.","journal-title":"Dis Model Mech"},{"key":"BFgt2015114_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1517\/14712598.2014.872237","volume":"14","author":"PJ Halonen","year":"2014","unstructured":"Halonen PJ, Nurro J, Kuivanen A, Yla-Herttuala S . Current gene therapy trials for vascular diseases. Expert Opin Biol Ther 2014; 14: 327\u2013336.","journal-title":"Expert Opin Biol Ther"},{"key":"BFgt2015114_CR4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.108.816454","volume":"119","author":"JE Lahteenvuo","year":"2009","unstructured":"Lahteenvuo JE, Lahteenvuo MT, Kivela A, Rosenlew C, Falkevall A, Klar J et al. Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms. Circulation 2009; 119: 845\u2013856.","journal-title":"Circulation"},{"key":"BFgt2015114_CR5","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1161\/01.CIR.0000115519.03688.A2","volume":"109","author":"J Rutanen","year":"2004","unstructured":"Rutanen J, Rissanen TT, Markkanen JE, Gruchala M, Silvennoinen P, Kivela A et al. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation 2004; 109: 1029\u20131035.","journal-title":"Circulation"},{"key":"BFgt2015114_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.gene.2013.03.051","volume":"525","author":"S Yla-Herttuala","year":"2013","unstructured":"Yla-Herttuala S . Cardiovascular gene therapy with vascular endothelial growth factors. Gene 2013; 525: 217\u2013219.","journal-title":"Gene"},{"key":"BFgt2015114_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/gt.2009.4","volume":"16","author":"M Hedman","year":"2009","unstructured":"Hedman M, Muona K, Hedman A, Kivela A, Syvanne M, Eranen J et al. Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer. Gene Therapy 2009; 16: 629\u2013634.","journal-title":"Gene Therapy"},{"key":"BFgt2015114_CR8","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/gt.2011.109","volume":"19","author":"K Muona","year":"2012","unstructured":"Muona K, Makinen K, Hedman M, Manninen H, Yla-Herttuala S . 10-year safety follow-up in patients with local VEGF gene transfer to ischemic lower limb. Gene Therapy 2012; 19: 392\u2013395.","journal-title":"Gene Therapy"},{"key":"BFgt2015114_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/gt.2011.43","volume":"18","author":"M Hedman","year":"2011","unstructured":"Hedman M, Hartikainen J, Yla-Herttuala S . Progress and prospects: hurdles to cardiovascular gene therapy clinical trials. Gene Therapy 2011; 18: 743\u2013749.","journal-title":"Gene Therapy"},{"key":"BFgt2015114_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/cvr\/cvp382","volume":"86","author":"J Huusko","year":"2010","unstructured":"Huusko J, Merentie M, Dijkstra MH, Ryhanen MM, Karvinen H, Rissanen TT et al. The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice. Cardiovasc Res 2010; 86: 122\u2013130.","journal-title":"Cardiovasc Res"},{"key":"BFgt2015114_CR11","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/sj.mt.6300175","volume":"15","author":"TT Rissanen","year":"2007","unstructured":"Rissanen TT, Yla-Herttuala S . Current status of cardiovascular gene therapy. Mol Ther 2007; 15: 1233\u20131247.","journal-title":"Mol Ther"},{"key":"BFgt2015114_CR12","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.1128\/JVI.76.9.4580-4590.2002","volume":"76","author":"AK Zaiss","year":"2002","unstructured":"Zaiss AK, Liu Q, Bowen GP, Wong NC, Bartlett JS, Muruve DA . Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J Virol 2002; 76: 4580\u20134590.","journal-title":"J Virol"},{"key":"BFgt2015114_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2174\/1381612043453379","volume":"10","author":"M Gruchala","year":"2004","unstructured":"Gruchala M, Roy H, Bhardwaj S, Yla-Herttuala S . Gene therapy for cardiovascular diseases. Curr Pharm Des 2004; 10: 407\u2013423.","journal-title":"Curr Pharm Des"},{"key":"BFgt2015114_CR14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/jgm.1600","volume":"13","author":"NB Wasala","year":"2011","unstructured":"Wasala NB, Shin JH, Duan D . The evolution of heart gene delivery vectors. J Gene Med 2011; 13: 557\u2013565.","journal-title":"J Gene Med"},{"key":"BFgt2015114_CR15","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1161\/CIRCRESAHA.114.302331","volume":"114","author":"S Zacchigna","year":"2014","unstructured":"Zacchigna S, Zentilin L, Giacca M . Adeno-associated virus vectors as therapeutic and investigational tools in the cardiovascular system. Circ Res 2014; 114: 1827\u20131846.","journal-title":"Circ Res"},{"key":"BFgt2015114_CR16","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/mt.2008.76","volume":"16","author":"C Zincarelli","year":"2008","unstructured":"Zincarelli C, Soltys S, Rengo G, Rabinowitz JE . Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther 2008; 16: 1073\u20131080.","journal-title":"Mol Ther"},{"key":"BFgt2015114_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/jgm.1576","volume":"13","author":"KM Prasad","year":"2011","unstructured":"Prasad KM, Smith RS, Xu Y, French BA . A single direct injection into the left ventricular wall of an adeno-associated virus 9 (AAV9) vector expressing extracellular superoxide dismutase from the cardiac troponin-T promoter protects mice against myocardial infarction. J Gene Med 2011; 13: 333\u2013341.","journal-title":"J Gene Med"},{"key":"BFgt2015114_CR18","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/jcmm.12242","volume":"18","author":"Q Li","year":"2014","unstructured":"Li Q, Xie J, Li R, Shi J, Sun J, Gu R et al. Overexpression of microRNA-99a attenuates heart remodelling and improves cardiac performance after myocardial infarction. J Cell Mol Med 2014; 18: 919\u2013928.","journal-title":"J Cell Mol Med"},{"key":"BFgt2015114_CR19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s00395-002-0360-0","volume":"97","author":"J Zhao","year":"2002","unstructured":"Zhao J, Pettigrew GJ, Thomas J, Vandenberg JI, Delriviere L, Bolton EM et al. Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo. Basic Res Cardiol 2002; 97: 348\u2013358.","journal-title":"Basic Res Cardiol"},{"key":"BFgt2015114_CR20","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1161\/01.CIR.0000065598.46411.EF","volume":"107","author":"S Fleury","year":"2003","unstructured":"Fleury S, Simeoni E, Zuppinger C, Deglon N, von Segesser LK, Kappenberger L et al. Multiply attenuated, self-inactivating lentiviral vectors efficiently deliver and express genes for extended periods of time in adult rat cardiomyocytes in vivo. Circulation 2003; 107: 2375\u20132382.","journal-title":"Circulation"},{"key":"BFgt2015114_CR21","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/mt.2008.61","volume":"16","author":"K Niwano","year":"2008","unstructured":"Niwano K, Arai M, Koitabashi N, Watanabe A, Ikeda Y, Miyoshi H et al. Lentiviral vector-mediated SERCA2 gene transfer protects against heart failure and left ventricular remodeling after myocardial infarction in rats. Mol Ther 2008; 16: 1026\u20131032.","journal-title":"Mol Ther"},{"key":"BFgt2015114_CR22","doi-asserted-by":"publisher","first-page":"e89979","DOI":"10.1371\/journal.pone.0089979","volume":"9","author":"MP Turunen","year":"2014","unstructured":"Turunen MP, Husso T, Musthafa H, Laidinen S, Dragneva G, Laham-Karam N et al. Epigenetic upregulation of endogenous VEGF-A reduces myocardial infarct size in mice. PLoS One 2014; 9: e89979.","journal-title":"PLoS One"},{"key":"BFgt2015114_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.hlc.2004.12.023","volume":"14","author":"A Terman","year":"2005","unstructured":"Terman A, Brunk UT . The aging myocardium: roles of mitochondrial damage and lysosomal degradation. Heart Lung Circ 2005; 14: 107\u2013114.","journal-title":"Heart Lung Circ"},{"key":"BFgt2015114_CR24","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1089\/hum.2013.2517","volume":"24","author":"MG Katz","year":"2013","unstructured":"Katz MG, Fargnoli AS, Williams RD, Bridges CR . Gene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: current concepts and future applications. Hum Gene Ther 2013; 24: 914\u2013927.","journal-title":"Hum Gene Ther"},{"key":"BFgt2015114_CR25","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/1743-422X-9-296","volume":"9","author":"R Toivonen","year":"2012","unstructured":"Toivonen R, Koskenvuo J, Merentie M, Soderstrom M, Yla-Herttuala S, Savontaus M . Intracardiac injection of a capsid-modified Ad5\/35 results in decreased heart toxicity when compared to standard Ad5. Virol J 2012; 9: 296\u2013422X-9-296.","journal-title":"Virol J"},{"key":"BFgt2015114_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0167-5273(02)00554-5","volume":"90","author":"G Vassalli","year":"2003","unstructured":"Vassalli G, Bueler H, Dudler J, von Segesser LK, Kappenberger L . Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors. Int J Cardiol 2003; 90: 229\u2013238.","journal-title":"Int J Cardiol"},{"key":"BFgt2015114_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ymthe.2006.03.014","volume":"14","author":"K Inagaki","year":"2006","unstructured":"Inagaki K, Fuess S, Storm TA, Gibson GA, Mctiernan CF, Kay MA et al. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Mol Ther 2006; 14: 45\u201353.","journal-title":"Mol Ther"},{"key":"BFgt2015114_CR28","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/sj.gt.3303029","volume":"14","author":"B Bostick","year":"2007","unstructured":"Bostick B, Ghosh A, Yue Y, Long C, Duan D . Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration. Gene Therapy 2007; 14: 1605\u20131609.","journal-title":"Gene Therapy"},{"key":"BFgt2015114_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/cvr\/cvv205","volume":"108","author":"MY Rincon","year":"2015","unstructured":"Rincon MY, VandenDriessche T, Chuah MK . Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation. Cardiovasc Res 2015; 108: 4\u201320.","journal-title":"Cardiovasc Res"},{"key":"BFgt2015114_CR30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2174\/157488606777934440","volume":"1","author":"T Wirth","year":"2006","unstructured":"Wirth T, Hedman M, Makinen K, Manninen H, Immonen A, Vapalahti M et al. Safety profile of plasmid\/liposomes and virus vectors in clinical gene therapy. Curr Drug Saf 2006; 1: 253\u2013257.","journal-title":"Curr Drug Saf"},{"key":"BFgt2015114_CR31","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jacc.2006.09.053","volume":"49","author":"S Yla-Herttuala","year":"2007","unstructured":"Yla-Herttuala S, Rissanen TT, Vajanto I, Hartikainen J . Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. J Am Coll Cardiol 2007; 49: 1015\u20131026.","journal-title":"J Am Coll Cardiol"},{"key":"BFgt2015114_CR32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/rmv.1762","volume":"23","author":"S Hareendran","year":"2013","unstructured":"Hareendran S, Balakrishnan B, Sen D, Kumar S, Srivastava A, Jayandharan GR . Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them. Rev Med Virol 2013; 23: 399\u2013413.","journal-title":"Rev Med Virol"},{"key":"BFgt2015114_CR33","first-page":"28","volume":"5","author":"E Basner-Tschakarjan","year":"2014","unstructured":"Basner-Tschakarjan E, Bijjiga E, Martino AT . Pre-clinical assessment of immune responses to adeno-associated virus (AAV) vectors. Front Immunol 2014; 5: 28.","journal-title":"Front Immunol"},{"key":"BFgt2015114_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2337\/db11-0763","volume":"61","author":"M Meloni","year":"2012","unstructured":"Meloni M, Descamps B, Caporali A, Zentilin L, Floris I, Giacca M et al. Nerve growth factor gene therapy using adeno-associated viral vectors prevents cardiomyopathy in type 1 diabetic mice. Diabetes 2012; 61: 229\u2013240.","journal-title":"Diabetes"},{"key":"BFgt2015114_CR35","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1089\/hum.2008.123","volume":"19","author":"LT Bish","year":"2008","unstructured":"Bish LT, Morine K, Sleeper MM, Sanmiguel J, Wu D, Gao G et al. Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. Hum Gene Ther 2008; 19: 1359\u20131368.","journal-title":"Hum Gene Ther"},{"key":"BFgt2015114_CR36","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nm1085","volume":"10","author":"P Gregorevic","year":"2004","unstructured":"Gregorevic P, Blankinship MJ, Allen JM, Crawford RW, Meuse L, Miller DG et al. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 2004; 10: 828\u2013834.","journal-title":"Nat Med"},{"key":"BFgt2015114_CR37","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/0002-8703(91)90531-L","volume":"122","author":"MS Hazen","year":"1991","unstructured":"Hazen MS, Marwick TH, Underwood DA . Diagnostic accuracy of the resting electrocardiogram in detection and estimation of left atrial enlargement: an echocardiographic correlation in 551 patients. Am Heart J 1991; 122: 823\u2013828.","journal-title":"Am Heart J"},{"key":"BFgt2015114_CR38","doi-asserted-by":"publisher","first-page":"H584","DOI":"10.1152\/ajpheart.00855.2005","volume":"290","author":"Q Li","year":"2006","unstructured":"Li Q, Guo Y, Tan W, Stein AB, Dawn B, Wu WJ et al. Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences. Am J Physiol Heart Circ Physiol 2006; 290: H584\u2013H589.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFgt2015114_CR39","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/sj.gt.3300938","volume":"6","author":"S Zolotukhin","year":"1999","unstructured":"Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Therapy 1999; 6: 973\u2013985.","journal-title":"Gene Therapy"},{"key":"BFgt2015114_CR40","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1038\/mt.2012.145","volume":"20","author":"J Huusko","year":"2012","unstructured":"Huusko J, Lottonen L, Merentie M, Gurzeler E, Anisimov A, Miyanohara A et al. AAV9-mediated VEGF-B gene transfer improves systolic function in progressive left ventricular hypertrophy. Mol Ther 2012; 20: 2212\u20132221.","journal-title":"Mol Ther"},{"key":"BFgt2015114_CR41","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/jgm.860","volume":"8","author":"PI Makinen","year":"2006","unstructured":"Makinen PI, Koponen JK, Karkkainen AM, Malm TM, Pulkkinen KH, Koistinaho J et al. Stable RNA interference: comparison of U6 and H1 promoters in endothelial cells and in mouse brain. J Gene Med 2006; 8: 433\u2013441.","journal-title":"J Gene Med"},{"key":"BFgt2015114_CR42","doi-asserted-by":"publisher","first-page":"e12639","DOI":"10.14814\/phy2.12639","volume":"3","author":"M Merentie","year":"2015","unstructured":"Merentie M, Lipponen JA, Hedman M, Hedman A, Hartikainen J, Huusko J et al. Mouse ECG findings in aging, with conduction system affecting drugs and in cardiac pathologies: Development and validation of ECG analysis algorithm in mice. Physiol Rep 2015; 3 pii e12639.","journal-title":"Physiol Rep"},{"key":"BFgt2015114_CR43","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1113\/jphysiol.2003.054064","volume":"555","author":"G Liu","year":"2004","unstructured":"Liu G, Iden JB, Kovithavongs K, Gulamhusein R, Duff HJ, Kavanagh KM . In vivo temporal and spatial distribution of depolarization and repolarization and the illusive murine T wave. J Physiol 2004; 555: 267\u2013279.","journal-title":"J Physiol"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt2015114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2015114","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2015114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T12:09:18Z","timestamp":1648555758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt2015114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,24]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFgt2015114"],"URL":"https:\/\/doi.org\/10.1038\/gt.2015.114","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,24]]},"assertion":[{"value":"20 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}